While blood and CSF have long dominated biomarker research, tear fluid is emerging as a scientifically relevant, non-invasive matrix for detecting systemic and neurological biomarkers. Produced by lacrimal glands and influenced by neural, immune, and endocrine pathways, tears contain cytokines and neuronal proteins that reflect both local and central pathophysiology.
With Simoa®’s ultra-sensitive immunoassay technology, researchers can now quantify low-abundance biomarkers in microliter volumes of tear fluid—opening new avenues in inflammation and neurodegeneration research.
In this app note, you’ll learn how:
Fill out the form to download your copy of the application note and explore how tears and Simoa® are redefining the future of immune monitoring.
 |
|
APP NOTE Expanding Access to Ultra-Sensitive Biomarker Testing: Urine as a Non-Invasive Matrix for Simoa Assays |
 |
|
PUBLICATION BRIEF Beyond Blood: Expanding Simoa Applications in Urine, Saliva, Sweat, & Tears |
 |
|
WEBINAR Decoding Alzheimer’s: The History, Biomarkers, and Clinical Advances |
